Anushka Asthana
Sunday September 11, 2005
The world's poorest people are being denied access to drugs
because pharmaceutical companies are focusing their
resources on diseases suffered by wealthy, middle-aged
Americans, such as obesity and heart disease, a leading
expert will say tomorrow.
Dr David Rhodes, the Health Protection Agency's (HPA) head
of business development, will claim that spiralling costs are
driving firms to invest primarily in drugs that tackle diseases of
'older Americans'.
As a result, the international market has been flooded with
medicines to treat 'American diseases' such as high blood
pressure, obesity, heart disease and cancer, while drugs to
tackle tuberculosis, malaria and water-borne diseases
prevalent in the poorest countries have been neglected.
Presenting his research at the HPA's annual conference
tomorrow, Rhodes will show that more and more
pharmaceutical companies are moving their headquarters to
the US in search of profits. Once there, they pump money into
treatments that help the local population to live longer.
http://observer.guardian.co.uk/international/story/0,6903,1567304,00.htmllet's see what tomorrow brings.
dp